AllStripes Research Inc., headquartered in the United States, is a pioneering force in the healthcare industry, specialising in rare disease research. Founded in 2020, the company has quickly established itself as a leader in leveraging patient data to accelerate drug development. With a focus on conditions that often go overlooked, AllStripes utilises innovative methodologies to gather and analyse real-world evidence, making it a unique player in the market. The company’s core services include data collection and analysis, which empower researchers and pharmaceutical companies to better understand rare diseases. AllStripes has achieved notable milestones, including partnerships with leading biopharmaceutical firms, enhancing its position as a trusted resource in the rare disease landscape. Through its commitment to improving patient outcomes, AllStripes continues to make significant strides in transforming the future of healthcare.
How does AllStripes Research Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
AllStripes Research Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AllStripes Research Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a merged entity, AllStripes Research Inc. may inherit climate commitments and data from its parent organisation; however, no specific details regarding such cascaded data are available. The lack of emissions reporting and reduction initiatives suggests that AllStripes Research Inc. is still in the early stages of establishing its climate strategy. In the broader context of the industry, companies are increasingly expected to set science-based targets and disclose their emissions to align with global climate goals. AllStripes Research Inc. will need to develop and communicate its climate commitments to meet these expectations and contribute to sustainability efforts.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AllStripes Research Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

